Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Evaluation of Two Response Thresholds to Continuous Ketone Monitoring Information Minimising Ketosis in People With Type 1 Diabetes Treated With Dapagliflozin

NCT07225465 is registered in ClinicalTrials.gov with St Vincent's Hospital Melbourne as lead sponsor.

NCT NCT07225465
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07225465 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Evaluation of Two Response Thresholds to Continuous Ketone Monitoring Information Minimising Ketosis in People With Type 1 Diabetes Treated With Dapagliflozin
Lead sponsor
St Vincent's Hospital Melbourne
Phase
Phase 2
Overall status
Not yet recruiting
Start date
February 28, 2026
Completion date
February 29, 2028
Enrollment
115 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes mellitus